DEMECAN-preview

Demecan

DEMECAN

Private

EbersbachHealthcare & Life Scienceshttps://demecan.de

Last Round

VC Round

Aug 7, 2024

Est. Valuation

$109.2M

Total Funding Raised

$17.23M

Momentum Score

50 /100

Company Overview

DEMECAN is a pharmaceuticals and biotechnology company that produces and supplies medical cannabis in Germany.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, E-commerce

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting, Marketplace Commission

AI Layer

Non-AI

Keywords

medical cannabiscannabis cultivationlicensed producercannabis wholesalepharmaceutical-grade cannabisEU-GMP certifiedGerman cannabis marketmedical marijuanavertically integrated cannabispharmacy distributiongovernment contractsin-house laboratorypharma supply chainBfArMdried cannabis flowercannabis extractsFederal Institute for Drugs and Medical Devicesonline pharmacy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DEMECAN Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DEMECAN Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Aug 7, 2024
VC Round	Dec 19, 2022
Series A Extension	Apr 15, 2021
Series A Extension	May 19, 2020
Series A	Oct 1, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Roman Faber

CFO - Power Of Attorney (Prokurist)

Executive Team

Sebastian Müllers

Chief Operating Officer (COO), Chief Operating Officer, COO

Executive Team

DEMECAN Investors

Notable investors and investment history

Investor	Rounds
b2venture	Series A
Trog Hawley Capital	VC Round
ENEXIS	VC Round
Futury Fund	Series A Extension

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 26, 2026
Expanding cultivation at Ebersbach site to boost domestic production capacity.
May 1, 2019
Awarded exclusive contract to produce medical cannabis in Germany.

View all signals

DEMECAN Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

DEMECAN Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DEMECAN's valuation, stock price, and market status.

Firmographic Details

HeadquartersEbersbach

Employee Range79

Year Founded2017

Last FundingAug 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.